Hester Biosciences Announces an Investment of $3 Million in Its Subsidiary
Shital Jibhe / 07 Jun 2017
Hester Biosciences Limited is engaged in manufacturing of poultry vaccines and large animal vaccines, and trading of poultry health products and large animal health products.
Hester Biosciences Limited is engaged in manufacturing of poultry vaccines and large animal vaccines, and trading of poultry health products and large animal health products. On Wednesday, it informed the bourses that its board of directors has approved to make an investment amounting to $3 million in its wholly owned subsidiary Hester Biosciences Africa.
As per BSE filing, the main business of the wholly owned subsidiary will be of manufacturing and trading of veterinary vaccines and health products.
In a year’s time, the stock has delivered over 45% returns. It has outperformed BSE Healthcare and underperformed BSE small-cap over the same period.
Meanwhile, Hester Biosciences was up by 2.9% at Rs 911 per share at 15:09 hours IST on BSE. It hit a high of Rs 911 and a low of Rs 888 so far during the day.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.